Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
about
The life and times of the EnterococcusRandomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infectionEfficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureusActivity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscessesVancomycin-resistant enterococci.Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisContinuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infectionsEfficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniaeAntimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureusCurrent perspectives on glycopeptide resistance.Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditisIssues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MICContinuous infusion of beta-lactam antibioticsSingle-dose antibiotic therapy: what has the past taught us?Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.Virulence of enterococci.The rise of the Enterococcus: beyond vancomycin resistance.Screening and treatment of infections caused by resistant enterococci.Mechanisms of resistance of enterococci to beta-lactam antibiotics.Therapy of enterococcal infections.Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosidesActivities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicinActivity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.Beta-lactam antibiotics: is continuous infusion the preferred method of administration?Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.Enterococcus, an emerging pathogen.
P2860
Q24616875-5C0C9BA3-B181-4B8E-AD12-B5700BA10FD4Q24675002-2EE5F603-D6A6-4046-9EAC-D838E0DA17D5Q28361126-227347D8-C850-4AE3-B7E4-3E99B8672FE9Q33748818-7DFF2970-DB14-449A-8CEE-E3F0F4B32CB3Q33975592-AE3DE8F9-3E36-43F5-88C9-8AAA1E70A33FQ35013772-D42D1C7E-547F-4DF5-AEC4-8BA78C09A105Q35121434-B32D8BF0-ACE9-4078-9C3A-5973EC05A736Q35123123-D5245644-BEF5-440D-9AE7-DAA39ADBC6B7Q35136019-8C97237F-13AA-40A9-ADC0-8AE5DCC70FCBQ35136449-3255F746-4244-4CE6-AAAA-E4836D8D4E4FQ35253384-64FEC93B-E5BA-4963-AD2A-84852AC06C03Q35368590-93CBA8B5-7A9C-4267-A368-E616B97FCF7BQ35534742-D1B801C4-4171-43E0-A9C7-C66B3E957E18Q35637864-90751DE0-EAFC-4EA8-A688-2E3679FBE115Q35656806-AB3CED22-09EC-41DB-B180-D92A54F76063Q35661686-A305373A-4417-4F67-8C47-485EA3B0DB1CQ35816904-32A6773B-0621-4703-8F26-BFC83A0D4FBDQ35819639-2532AFE1-4997-4D63-8843-66630308CE79Q35823261-515E454C-F6ED-4A79-B507-24460D8877CAQ35843281-0E4AAC68-8DFB-4242-8581-7C5350A09460Q36641988-78412F2D-02A0-4E1C-88E2-680D6CE9B8CBQ36752156-009A060D-DC53-42E2-999E-C0E611C84BB2Q37711795-FFF2D989-9C1B-499F-A013-5FCD4843EB3FQ37909566-4F532707-9C4E-46DA-9B19-7124B7A24D36Q37909576-738959ED-D27F-4F61-8877-79F3354D5E5CQ39470313-614C6E51-9AFD-4BCB-B12E-47A78856599AQ39472331-45248DC9-2574-4E82-B215-FBC9399DF358Q39475317-8EA1B8F6-9CDD-4400-BBE1-7E0C557C3763Q39475968-5D609123-9851-4A1A-BCC8-4A7847369BA4Q39746366-703896D2-7693-4952-9870-A7A28886B460Q39815914-EC3E35EB-A34F-4868-B3DF-9C242211E1C7Q39816575-18A654CA-5774-4BD1-90D1-BEA45FE1A3CBQ39816811-D3BCF152-9E82-4C05-98BD-A8DB133D5D23Q39833014-3E743512-E4F2-43B0-83F2-5653086BB45CQ39865205-77E097CD-4451-4BF2-AD81-2B2C5BA2BE60Q39874965-735DD92A-3E7E-4076-B295-EF3E59C06838Q40284385-A47ADBB3-BC37-4A07-AE77-D03080D3D70EQ40459002-2EBE9496-7E98-49A6-B50D-502B47E7C576Q40688395-1FE743DA-BAE6-4FF6-A82E-6273031F804BQ40785841-B7110E1C-6263-41FC-A688-0F63A6F1C1DC
P2860
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@ast
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@en
type
label
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@ast
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@en
prefLabel
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@ast
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@en
P2093
P2860
P356
P1476
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
@en
P2093
Eliopoulos GM
Moellering RC Jr
Wennersten C
P2860
P304
P356
10.1128/AAC.31.2.139
P407
P577
1987-02-01T00:00:00Z